Status:
UNKNOWN
(VIII): The Eight Study and Immunologic Response Sub-study
Lead Sponsor:
physIQ, Inc.
Conditions:
Vaccine Reaction
Eligibility:
All Genders
Brief Summary
The study's objective is to test the hypothesis that immune system activation and subsequent systemic inflammation can be detected through continuously tracking multiple bio signals including physiolo...
Eligibility Criteria
Inclusion
- Is 18 years of age or older.
- Is able to speak and read English.
- Plan to receive either the Moderna or Pfizer vaccine (mRNA vaccine).
- No known prior COVID-19 infection.
Exclusion
- Known allergy to the adhesive used on the VitalPatch.
Key Trial Info
Start Date :
April 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 15 2022
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT05237024
Start Date
April 15 2021
End Date
December 15 2022
Last Update
February 11 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
physIQ
Chicago, Illinois, United States, 60606
2
Cell Carta
Montreal, Quebec, Canada, H2X 3A3